Anti-Cancer Activity of a 5-Aminopyrazole Derivative Lead Compound (BC-7) and Potential Synergistic Cytotoxicity with Cisplatin against Human Cervical Cancer Cells

The use of some very well-known chemotherapeutic agents, such as cisplatin, is limited by toxicity in normal tissues and the development of drug resistance. In order to address drug resistance and the side-effects of anti-cancer agents, recent research has focused on finding novel combinations of an...

Descripción completa

Detalles Bibliográficos
Autores principales: Swanepoel, Bresler, Nitulescu, George Mihai, Olaru, Octavian Tudorel, Venables, Luanne, van de Venter, Maryna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888365/
https://www.ncbi.nlm.nih.gov/pubmed/31703393
http://dx.doi.org/10.3390/ijms20225559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888365/
https://www.ncbi.nlm.nih.gov/pubmed/31703393
http://dx.doi.org/10.3390/ijms20225559

Ejemplares similares